Showing results (151-160 of 312) with videos related to

Sort By:
Pageof 32
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 25, 2019
Efficient Intestinal Digestion and On Site Tumor-Bioactivation are the Two Important Determinants for Chylomicron-Mediated Lymph-Targeting Triglyceride-Mimetic Docetaxel Oral ProdrugsChutong Tian, Jingjing Guo, Gang Wang, et al.
Chemical Communications (Cambridge, England)|February 15, 2022
Ag(I)/PPh3-catalyzed diastereoselective syntheses of spiro[indole-3,4'-piperidine] derivatives via cycloisomerizations of tryptamine-ynamidesYanyu Chen, Zhaobo Wang, Wutong Zhao, et al.
Organic Letters|September 14, 2022
Gold(I)-Catalyzed Tandem Intramolecular Methoxylation/Double Aldol Condensation Strategy Yielding 2,2'-Spirobi[indene] DerivativesJingfu Zhang, Sen Zhang, Zhixing Ding, et al.
European Journal of Medicinal Chemistry|May 31, 2017
Design, synthesis and evaluation of aromatic heterocyclic derivatives as potent antifungal agentsShizhen Zhao, Xiangqian Zhang, Peng Wei, et al.
European Journal of Medicinal Chemistry|September 22, 2019
Combating fluconazole-resistant fungi with novel β-azole-phenylacetone derivativesLiyu Zhao, Nannan Sun, Linfeng Tian, et al.
European Journal of Medicinal Chemistry|June 14, 2014
The use of hairpin DNA duplexes as HIV-1 fusion inhibitors: synthesis, characterization, and activity evaluationLiang Xu, Xifeng Jiang, Xiaoyu Xu, et al.
Physical Chemistry Chemical Physics : PCCP|May 23, 2024
Application of molecular dynamics-based pharmacophore and machine learning approaches to identify novel Mcl1 inhibitors through drug repurposing and mechanics researchHanxun Wang, Zhuo Qi, Wenxiong Lian, et al.
Organic Letters|December 15, 2022
Asymmetric Total Synthesis of Neobraclactone CXinhang Zhang, Hanyang Sun, Changhong Han, et al.
Clinical and Translational Medicine|March 29, 2025
PCIF1 drives oesophageal squamous cell carcinoma progression via m6Am-mediated suppression of MTF2 translationKang Li, Yuxuan Yi, Rongsong Ling, et al.
Molecules (Basel, Switzerland)|February 15, 2018
Discovery of 2-(4-Substituted-piperidin/piperazine-1-yl)-N-(5-cyclopropyl-1H-pyrazol-3-yl)-quinazoline-2,4-diamines as PAK4 Inhibitors with Potent A549 Cell Proliferation, Migration, and Invasion Inhibition ActivityTianxiao Wu, Yu Pang, Jing Guo, et al.
Pageof 32